Pacelli Steven Robert's Form 4 filing
Dexcom Inc (DXCM) · filed Oct 23, 2023
- Accession no.
- 0001093557-23-000209
- Filed
- Oct 23, 2023
- Trade date
- Oct 23, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $35.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pacelli Steven RobertCIK 0001359098 | Officer (EVP Managing Director Dexcom V) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | Common Stock | SSaleDisposed | −411 | $85.75 | −$35,243.25 | 125,186 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.